US approves treatment for lazy eye

Israel’s NovaSight (see here previously) has received FDA approval for its CureSight digital therapy device for amblyopia (lazy eye). Clearance was given following a multicenter, randomized, controlled trial of 103 participants under 9 years of age. 79% of children improved in the trial.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *